AccuStem Sciences, Inc. (ACUT)
OTCMKTS
· Delayed Price · Currency is USD
0.474
0.00 (0.00%)
At close: Jan 17, 2025
AccuStem Sciences Statistics
Total Valuation
AccuStem Sciences has a market cap or net worth of 4.16 million. The enterprise value is 4.18 million.
Market Cap | 4.16M |
Enterprise Value | 4.18M |
Important Dates
The next estimated earnings date is Friday, February 14, 2025.
Earnings Date | Feb 14, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
AccuStem Sciences has 11.35 million shares outstanding. The number of shares has decreased by -0.01% in one year.
Current Share Class | n/a |
Shares Outstanding | 11.35M |
Shares Change (YoY) | -0.01% |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 41.70% |
Owned by Institutions (%) | n/a |
Float | 5.28M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | n/a |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -3.03 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.03
Current Ratio | 0.03 |
Quick Ratio | 0.01 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -476.99% |
Return on Capital (ROIC) | n/a |
Revenue Per Employee | n/a |
Profits Per Employee | -459,681 |
Employee Count | 3 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -20.96% in the last 52 weeks. The beta is 3.03, so AccuStem Sciences's price volatility has been higher than the market average.
Beta (5Y) | 3.03 |
52-Week Price Change | -20.96% |
50-Day Moving Average | 0.35 |
200-Day Moving Average | 0.46 |
Relative Strength Index (RSI) | 49.23 |
Average Volume (20 Days) | 12,647 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 0.56 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -1.38M |
Pretax Income | -1.38M |
Net Income | -1.38M |
EBITDA | -1.38M |
EBIT | -1.38M |
Earnings Per Share (EPS) | -0.12 |
Balance Sheet
The company has 37,080 in cash and 57,597 in debt, giving a net cash position of -20,517 or -0.00 per share.
Cash & Cash Equivalents | 37,080 |
Total Debt | 57,597 |
Net Cash | -20,517 |
Net Cash Per Share | -0.00 |
Equity (Book Value) | -3.19M |
Book Value Per Share | -0.28 |
Working Capital | -3.19M |
Cash Flow
Operating Cash Flow | -959,511 |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
AccuStem Sciences does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 0.01% |
Shareholder Yield | 0.01% |
Earnings Yield | -33.12% |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |